SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > RXI Pharmaceuticals Corp (RXII)

Company logo. images.investorshub.advfn.com/images/uploads/2012/5/17/rtkhgrxii.jpg

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
PoemStone Member Profile
 
Followed By 858
Posts 27,865
Boards Moderated 1
Alias Born 11/05/10
160x600 placeholder
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 8/18/2017 5:24:07 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 8/18/2017 5:19:08 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/10/2017 7:17:15 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/10/2017 7:08:44 AM
RXi Pharmaceuticals Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights "PR Newswire (US)" - 8/10/2017 7:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 8/9/2017 4:48:43 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/9/2017 7:40:18 AM
RXi Pharmaceuticals Enters into Common Stock Purchase Agreement for Up to $15.0 Million "PR Newswire (US)" - 8/9/2017 7:05:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 8/9/2017 6:05:04 AM
RXi Pharmaceuticals Advances Immuno-Oncology Pipeline by Selecting Two sd-rxRNA Compounds for Preclinical Development and Sou... "PR Newswire (US)" - 8/8/2017 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/3/2017 8:07:27 AM
RXi Pharmaceuticals Granted 180-Day Extension by Nasdaq Stock Market to Regain Compliance with Listing Requirements "PR Newswire (US)" - 8/3/2017 8:05:00 AM
RXi Pharmaceuticals to Webcast Second Quarter 2017 Financial Results on Thursday, August 10, 2017 "PR Newswire (US)" - 8/3/2017 7:05:00 AM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 7/31/2017 5:31:39 PM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 7/14/2017 5:18:33 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/26/2017 8:24:30 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/22/2017 11:50:31 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 6/22/2017 6:01:46 AM
RXi Pharmaceuticals Announces Completion of Enrollment of Phase 1/2 Clinical Trial with RXI-109 for Retinal Scarring "PR Newswire (US)" - 6/21/2017 7:05:00 AM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 6/16/2017 5:24:00 PM
RXi Pharmaceuticals Announces the Initiation of its Consumer Testing Program with RXI-231 "PR Newswire (US)" - 6/12/2017 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/9/2017 5:22:12 PM
RXi Pharmaceuticals to Present at the Marcum MicroCap Conference "PR Newswire (US)" - 6/8/2017 7:05:00 AM
RXi Pharmaceuticals Corporation Announces the Appointment of Dr. Jonathan Freeman to its Board of Directors "PR Newswire (US)" - 6/7/2017 7:05:00 AM
RXi Pharmaceuticals to Present at the 3rd Annual Immuno-Oncology BD&L and Investment Forum "PR Newswire (US)" - 5/23/2017 7:05:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist